Posted
Nestle will pay $2 billion to buy the remaining stake in Aimmune Therapeutics Inc, gaining full ownership of the first U.S.-approved peanut allergy treatment. Conway G. Gittens reports.
01:18
01:33
01:41
01:03
02:11
02:08
01:21
01:31
01:24
01:09
01:13
02:01
02:22
01:25
02:04
01:08
01:16
02:05
02:09
01:26
01:26
01:38
01:27
01:22
01:40
02:02
10:43
01:45
02:08
01:09
01:47
01:25
01:30
01:50
03:06
01:10
01:08
01:47
01:42
02:12
01:47
00:45
01:37
02:56
02:15
01:34
03:51
00:27
01:26
01:49
02:21
00:42
00:53
01:47
02:10
02:04
02:26
01:04
01:34
01:06
02:12
01:17
01:56
01:32
01:41
01:46
01:45
01:07
01:02
01:35
01:23
02:06
01:18
00:37
01:20
01:02
01:44
01:03